MHC Class II (I-A/I-E) -KO

Nomenclature

C57BL/6Smoc-H2-Ab1em1H2-Aaem1 H2-Eb1em1H2-Eb2em1H2-Ea-ps em1 Smoc

Cat. NO.

NM-KO-18032

Strain State

Repository Live

Export PDF

Model Description

All sequences from the upstream of mouse H2-Ab1 gene exon 2 to the upstream of the H2-Ea-ps gene exon 1 were knocked out to obtain H2-Ab1、H2-Aa、H2-Eb1、H2-Eb2、H2-Ea-ps knockout mouse models. These MHC class II molecule-deficient mice were on the C57BL/6J genetic background and also lacked cell surface expression of both class II-A and class II-E MHC proteins.
Research Application：immune system

Validation Data

image.png

Fig.1 Detection of MHC Class II (I-A/I-E) expression in blood of female HO MHC Class II (I-A/I-E) -KO mice. 

Abbr.  WT, wild type; HO, homozygous.

image.png

Fig.2 Detection of MHC Class II (I-A/I-E) expression in spleen of female HO MHC Class II (I-A/I-E) -KO mice. 

Abbr.  WT, wild type; HO, homozygous.

image.png

Fig.3 Detection of immune cell subsets in blood and spleen of HO MHC Class II (I-A/I-E) -KO mice (two female mice in both groups).

Abbr.  WT, wild type; HO, homozygous.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more